PEDONCOVID - SFCE national cohort on SARS-CoV-2 (COVID-19) infections in paediatric oncology-haematology

Head :
ROUGER-GAUDICHON Jérémie

Last update : 05/05/2021 | Version : 1 | ID : 73865

print
Print
xml
XML

Export to XML

Please choose the format :

pdf
PDF
xml
CSV (Excel)

Export to CSV

What sections do you want to export ?

Métadonnées
Identification
General Aspects
Scientific investigator(s) (Contact)
Collaborations
Funding
Governance of the database
Additional contact
Type of database
Database objective
Population type
Dates
Size of the database
Data
Procedures
Promotion
Access
Select all | Invert selection | No selection

Which version do you want to export ?

send
Send
General
Identification
Detailed name SFCE national cohort on SARS-CoV-2 (COVID-19) infections in paediatric oncology-haematology
Sign or acronym PEDONCOVID
General Aspects
Medical area Pediatrics
Study in connection with Covid-19 Yes
Pathology (details) Paediatric oncology
Keywords cancer; paediatrics; chemotherapy; SARS-CoV-2; COVID-19
Scientific investigator(s) (Contact)
Name of the director ROUGER-GAUDICHON
Surname Jérémie
Organization CHU Caen Normandie
Collaborations
Funding
Governance of the database
Sponsor(s) or organisation(s) responsible CHU Caen Normandie
Organisation status Public
Additional contact
Main features
Type of database
Type of database Study databases
Study databases (details) Cohort study
Database recruitment is carried out by an intermediary A selection of health institutions and services
Database recruitment is carried out as part of an interventional study No
Database objective
Main objective Describe the presentation and clinical course of SARS-CoV-2 infection among patients followed up in a paediatric oncology-haematology department or young adult and adolescent unit at an SFCE centre, for cancer or a benign tumour treated with chemotherapy, radiotherapy or targeted therapy.
Inclusion criteria Children and legal representatives, or adult patients having received information on the study
AND
- Patient followed up in a paediatric oncology-haematology department or young adult and adolescent unit at an SFCE centre for cancer or a benign tumour treated with chemotherapy, radiotherapy or targeted therapy, with a cancer treatment either ongoing or completed within the past 6 months, or a history of allogeneic haematopoietic stem cell transplantation with immunosuppressant therapy ongoing or discontinued within the past 6 months, or a history of CAR-T cell therapy
AND
- Diagnosis of SARS-CoV-2 infection confirmed by PCR or positive IgM serology
OR
- Clinical and radiological diagnosis characteristic of SARS-CoV-2 infection without confirmation of infection by PCR or positive IgM serology with:
o Presence of at least 2 of the following signs in the event of contact with a subject currently presenting SARS-CoV-2 positive infection, or 3 of the following signs in the absence of contact: fever, cough, dysgeusia, dysosmia, myalgia, chest pain, dyspnoea, signs of respiratory distress, rhinorrhoea or nasopharyngeal congestion, diarrhoea, headaches, recent onset or exacerbation of asthenia and rash.
AND
o One or more radiological abnormalities observed on chest CT scan compatible with a diagnosis of COVID-19: peripheral and/or subpleural and/or bilateral ground-glass opacities, intralobular thickening with a “crazy-paving” appearance, linear condensations with or without peripheral halo (reverse halo sign).
Population type
Age Newborns (birth to 28 days)
Infant (28 days to 2 years)
Early childhood (2 to 5 years)
Childhood (6 to 13 years)
Adolescence (13 to 18 years)
Population covered Sick population
Pathology II - Neoplasms
Gender Male
Woman
Geography area National
Data collection
Dates
Size of the database
Size of the database (number of individuals) < 500 individuals
Data
Database activity Current data collection
Type of data collected Clinical data
Biological data
Clinical data (detail) Direct physical measures
Presence of a biobank No
Procedures
Followed pathology
Promotion and access
Promotion
Access

Partners - FAQ - Contact - Site map - Legal notices - Administration - Updated on December 15 2020 - Version 4.10.05